Gemini Notebook walkthrough of proteomic aging clocks in a phase 2a clinical trial
creatoroff · x · 2026-09-09
A shared Gemini Notebook breaks down one of the more promising recent biology results: integrating proteomic aging clocks into a phase 2a clinical trial to support simultaneous geroprotective assessment.
The paper, by Alex Zhavoronkov, Vadim Gladyshev and collaborators, brings proteomic aging clocks into clinical trials to evaluate anti-aging interventions in parallel — a notable step toward clinical use. The post itself is a retweet recommendation; the substance lives in the paper and notebook.
More from Research
- Timothy Duff's ECCV 2026 SfM-DL workshop slides on algebraic optimality for minimal solvers — ducha_aiki · 2026-09-09
- Drop a fixed batch proportion instead of per-sample tokens: capi author shares training trick — giffmana · 2026-09-09
- Adding Greek to a Cosmos3 VLA policy: bilingual training helps but lags far behind English — KIEFERSA · 2026-09-09
- Transformers encode a partner's expertise early but only act on it in later layers — Mika Okamoto · 2026-09-09
- Cadence uses a time-series foundation model for error-bounded lossy compression of demand data — Roberto Tacconelli · 2026-09-09
- Fourth Perception Test Challenge at ECCV 2026 pushes multimodal models on city-scale spatial intelligence — AjdDavison · 2026-09-09